Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of mesalazine for immune checkpoint inhibitor-induced colitis
jRCT2061240103Phase 2Suspended
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Colitis and diarrhea comparing Mesalazine arm with Placebo arm (2 arms). Started Jun 2025; status: suspended.
02
Drugs
Salcrozine
03
Conditions
Colitisdiarrhea
Beyond the preview
Go deeper on jRCT2061240103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2061240103.